The review is done in collaboration with the MRC-NIHR Trials Methodology Research Partnership. Our objective is to provide rapid review of publications, preprints and protocols from clinical trials of COVID-19 treatments.
-
-
Show this thread
-
We aim to provide timely, constructive, focused, clear advice aimed at improving both the research outputs under review, as well as future studies.
Show this thread -
Given our collective expertise (clinical trial statistics) our reviews will focus on the designs of the trials and other statistical content (methods, presentation and accuracy of results, inferences).
Show this thread
End of conversation
New conversation -
-
-
Great job. Do you have any information on what’s going on in NY? Some pubs say they are using “trial drugs” (the ones from the trial u review), other pubs say “running a trial”???pic.twitter.com/tyna9BRGVe
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
So good!!! Not that the stuff doesn't work, that sucks. But the review & that you're doing more of them.


Thank you! -
Oops - I mean, that this trial didn't show the stuff works of course.
End of conversation
New conversation -
-
-
Thanks for sharing. The Indian govt just issued an advisory recommending it's prophylactic use for asymptomatic healthworkers and contacts of cases.pic.twitter.com/moUfrbeEl9
-
Terrifying stuff if based on this study
End of conversation
New conversation -
-
-
Excuse me, where is your prestige published CNS paper telling us how you discovered the cure? You're never going to get attention or citations doing this boring number crunching!
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thank you taking your time for that. Just a BIG thank you!
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.